Scarica l'app Stockscreener
729.38
4.76%
33.78
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LLY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Lilly Eli Co Borsa (LLY) Ultime notizie
Eli Lilly & Co Completes $6.71 Billion Notes Issuance - TipRanks
Eli Lilly Neuroscience Head Anne White to Retire After Three Decades with Company - geneonline.com
Lilly searching for new neuro chief as White set to retire - BioPharma Dive
Novo Nordisk Freezes Hiring As Wegovy Faces Copycats - Benzinga
What's Going on With Eli Lilly Stock? - The Motley Fool
30-Year Veteran Who Led Lilly's Historic Alzheimer's Drug Launch: Anne White Announces Retirement - Stock Titan
Stock Option Traders Smell Blood in the Water After Eli Lilly’s (LLY) Q2 Fumble - TipRanks
New Obesity Drugs May See Premium Pricing Undermined By Underwhelming Data - Benzinga
Eli Lilly (LLY) Sells Record $6.75 Billion of Corporate Bonds - TipRanks
How does Viking’s oral obesity drug stand up to those of Eli Lilly and Novo? - Seeking Alpha
Mixed options sentiment in Eli Lilly with shares up 1.67% - TipRanks
Eli Lilly & Co’s Orforglipron Faces Hold Rating Amid Concerns Over GI Side Effects in Clinical Trials - TipRanks
Positive Market Outlook for Eli Lilly’s Orforglipron Following ATTAIN-1 Trial Results - TipRanks
Like Eli Lilly, Viking Therapeutics' Oral Weight Loss Drug Disappoints, Stock Tanks - Benzinga
Eli Lilly Considering Viking Therapeutics Acquisition?… - inkl
Eli Lilly Considering Viking Therapeutics Acquisition? Expert Says 'They're Setting Up For Something BIG' As LLY Issues 40-Year BondInvesco QQQ Trust, Series 1 (NASDAQ:QQQ), Eli Lilly (NYSE:LLY) - Benzinga
Eli Lilly (NYSE:LLY): This US$700bn company is set to beat Novo Nordisk & Ozempic even with this month's hiccup - Stocks Down Under
Analysts Rally Behind Eli Lilly (LLY) Stock After 24% Slide - TipRanks
Eli Lilly Files for $6.75 Billion Bond Offering - AInvest
Eli Lilly files for six-part notes offering of up to $6.75 billion - MarketScreener
Eli Lilly Taps High-Grade Bond Market With Rare 40-Year Paper - Bloomberg.com
Eli Lilly Launches $6.75 Billion Debt Offering - MarketScreener
Wall Street sees new obesity pills as priced near Wegovy and Zepbound - Reuters
Eli Lilly and Company Stock (LLY) Opinions on Orforglipron Trial Data - Quiver Quantitative
Eli Lilly Taps High-Grade Market With Rare 40-Year Paper - Yahoo Finance
Lilly Stock Down 5% This Month: Should You Buy the Dip? - uk.finance.yahoo.com
Superluminal joins a $1.3B deal with series A backer Lilly - BioWorld MedTech
Form 424B2 ELI LILLY & Co - StreetInsider
Daiwa Securities Downgrades Eli Lilly to Neutral From Outperform, Cuts Price Target to $700 From $940 - MarketScreener
The stock price pullback creates a good buying opportunity, and Eli Lilly and Co may soon join the "trillion-dollar club." - 富途牛牛
Superluminal Medicines, Eli Lilly forge USD 1.3 billion alliance to advance Small Molecule Therapeutics - Medical Dialogues
Eli Lilly and Company (LLY) Announces Results From LTE of Phase 3 TRAILBLAZER-ALZ 2 Study - uk.finance.yahoo.com
Eli Lilly: A Biotech Powerhouse Rewriting the Rules of Long-Term Growth - AInvest
Eli Lilly: Don't Bet Against This Biotech Powerhouse (NYSE:LLY) - Seeking Alpha
Eli Lilly's Q2 2025 Outperformance and Orforglipron Pipeline: A New Era for Obesity and Diabetes Therapies - AInvest
Eli Lilly (LLY) Raises Mounjaro Prices in UK, Stock Reacts Positively - MSN
Eli Lilly and Company (LLY) Releases Q2 2025 Results - uk.finance.yahoo.com
Eli Lilly’s Stock Soars Amid Promising Trials - TipRanks
Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet. - AOL.com
Novo Nordisk vs. Eli Lilly: Is the GLP-1 Correction Over, and Who's Better Positioned for Long-Term Leadership? - AInvest
Insider Moves: Microsoft, AMD, Boeing, AbbVie, Eli Lilly - TipRanks
Did Eli Lilly Stock Just Have Its Novo Nordisk Moment? - MSN
Eli Lilly Insider Buying: Lucas Montarce Purchases 715 Shares - AInvest
LLY CFO Makes Significant Investment in Eli Lilly & Co Stock - AInvest
Eli Lilly to sell troubled N.J. pharmaceutical plant, but says jobs are safe. Here’s why. - MSN
Eli Lilly & Co’s CFO Makes a Bold Move with New Stock Purchase! - TipRanks
Eli Lilly and Co Options Spot-On: On August 15th, 243.55K Contracts Were Traded, With 573.94K Open Interest - 富途牛牛
Eli Lilly & Co. hikes UK weight-loss drug’s price amid pressure from Trump - WISH-TV
Eli Lilly: Bet Against Insiders (NYSE:LLY) - Seeking Alpha
Eli Lilly (LLY) CEO Buys $1 Million of Company Stock After Recent Crash - MSN
Eli Lilly and health-care stocks are week's big winners, 3 sectors in the red - CNBC
Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst - Yahoo Finance
Eli Lilly Faces Lawsuit, Partnership and New Therapeutics Bolster Innovation - AInvest
Lilly signs $1.3 billion deal with Superluminal to discover obesity medicines using AI - Reuters
Texas Lawsuit Filed Against Eli Lilly (LLY) Amid New Cardio Collaboration - simplywall.st
Jim Cramer Says Eli Lilly Stock (LLY) Has Been ‘Laid to Waste’ - TipRanks
Eli Lilly and Co: Steve Mandel's Strategic Exit with a -3.94% Portfolio Impact - Yahoo Finance
Eli Lilly hikes Mounjaro prices in the UK to make weight-loss drug cheaper in the US - KTVZ
UK patients rush for obesity jab before Eli Lilly raises price 170% to appease Donald Trump - Financial Times
1.05%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):